DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

27.80 0.66 (2.43%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLDX $27.80 2.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.19
Previous Close $27.14
Daily Range $27.10 - $28.07
52-Week Range $11.93 - $32.82
Market Cap $2.7B
P/E Ratio -20.56
Dividend (Yield) $0.00 (0.0%)
Volume 951,989
Average Daily Volume 1,953,348
Current FY EPS -$1.39




Drug Makers

Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website:

News & Commentary Rss Feed

3 Tiny Healthcare Stocks You Ought to Be Watching

Celldex Therapeutics, Inc., Exact Sciences Corporation, and Sangamo Biosciences could all have market moving news this year.

Next Week In Biotech: Salix/Valeant PDUFA, ASCO, Brain Tumor Summit

Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!

Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts

Use Options For a Chance To Buy CLDX at a 47% Discount

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Celldex 1Q Loss Narrower-Than-Expected, Pipeline in Focus - Analyst Blog

Celldex 1Q Loss Narrower-Than-Expected, Pipeline in Focus - Analyst Blog

Celldex Therapeutics, Inc. Off to a Good Start in 2015

Celldex reports Q1 results with an eye towards bright things ahead in 2015.

Celldex Therapeutics (CLDX) Crumbles: Stock Slumps by 15.9% - Tale of the Tape

Today's Dead Cat Bounce Stock Is Celldex Therapeutics (CLDX)

See More CLDX News...

CLDX's Top Competitors

CLDX $27.80 (2.43%)
Current stock: CLDX
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB